Who owns CARISMA THERAPEUTICS INC?
- Ticker: CARM
- CUSIP Number: 14216r101
Tip: Access positions for across all investors
Analyze quarterly positions in Carisma Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Carisma Therapeutics stock
Who bought or sold CARISMA THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Merck & Co | 1.5M | $48k | 0% | Mar 2026 |
|
| XTX Topco | 40k | $1.7k | 100% | Dec 2025 |
|
| Empowered Funds | 31k | $1.3k | 0% | Dec 2025 |
|
| Union Bancaire Privee, UBP SA | 785.00 | $21.980000 | 0% | Mar 2026 |
|
| ORG Partners | 200.00 | $8.000000 | 0% | Dec 2025 |
|
| Golden State Equity Partners | 200.00 | $6.000000 | 100% | Mar 2026 |
|
Who sold out of Carisma Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Vanguard Group | Sep 2025 | 350k | $96k |
| Renaissance Technologies | Sep 2025 | 294k | $81k |
| State Street Corporation | Sep 2025 | 85k | $23k |
| Northern Trust | Sep 2025 | 55k | $15k |
| Gts Securities | Sep 2025 | 50k | $14k |
| Bridgeway Capital Management | Sep 2025 | 31k | $8.5k |
| Virtu Financial | Sep 2025 | 23k | $6.0k |
| Baader Bank | Dec 2025 | 20k | $517.147500 |
| Jpmorgan Chase & Co | Sep 2025 | 921.00 | $251.985600 |
| IFP Advisors | Dec 2025 | 206.00 | $9.002200 |